Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
*DJ Nestle Now Has Around 84% of Aimmune Therapeutics Shares
*DJ雀巢現在擁有AImmune治療公司約84%的股份
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:18 ET (05:18 GMT)
2020年10月13日東部時間01：18(格林尼治標準時間05：18)
*DJ Nestle's Subsidiary SPN MergerSub Offered $34.5 for Each Aimmune Therapeutics Share Not Owned by Nestle
*DJ雀巢的子公司SPN MergerSub出價34.5美元，收購每股非雀巢擁有的AImmune Treateutics股票
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:21 ET (05:21 GMT)
2020年10月13日東部時間01：21(格林尼治標準時間05：21)
*DJ Nestle: Minimum Tender Condition Has Been Satisfied
*DJ雀巢：已滿足最低投標條件
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:22 ET (05:22 GMT)
2020年10月13日東部時間01：22(格林尼治標準時間05：22)
*DJ Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
*DJ雀巢希望將SPN MergerSub子公司與AImmune Treeutics合併
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:24 ET (05:24 GMT)
2020年10月13日東部時間01：24(格林尼治標準時間05：24)
DJ Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
DJ雀巢完成對AImmune治療公司股票的購買；計劃與子公司合併
By Joshua Kirby
約書亞·柯比(Joshua Kirby)著
Nestle SA said Tuesday that it has bought a number of shares in Aimmune Therapeutics Inc., taking its holding in the pharmaceutical company to 84%.
雀巢公司(Nestle SA)週二説，它已經購買了AImmune治療公司(AImmune Treateutics Inc.)的一些股票，使其在這家制藥公司的持股比例達到84%。
The Swiss food-and-beverage conglomerate said its wholly-owned subsidiary SPN MergerSub had purchased around 43.4 million shares via a tender offer at a price of $34.50 per share. Added to the shares already owned by Nestle and its subsidiaries, it represents around 84% of the outstanding shares in Aimmune Therapeutics, the company said.
這家瑞士食品和飲料集團表示，其全資子公司SPN MergerSub已通過收購要約以每股34.50美元的價格購買了約4340萬股票。雀巢公司表示，加上雀巢及其子公司已經擁有的股份，它約佔AImmune治療公司流通股的84%。
SPN MergerSub will be merged with Aimmune Therapeutics, which will continue as the surviving corporation, Nestle said.
雀巢表示，SPN MergerSub將與AImmune Treeutics合併，後者將繼續作為倖存的公司。
Write to Joshua Kirby at joshua.kirby@dowjones.com
寫信給喬舒亞·柯比(Joshua Kirby)，電子郵件：joshoa.kirby@dowjones.com
(END) Dow Jones Newswires
(完)道瓊通訊社
October 13, 2020 01:45 ET (05:45 GMT)
2020年10月13日東部時間01：45(格林尼治標準時間05：45)
Copyright (c) 2020 Dow Jones & Company, Inc.
版權所有(C)2020道瓊斯公司。